Related Experiment Videos
Uncommon invasive fungal pathogens in the acquired immunodeficiency syndrome
J R Perfect1, W A Schell, M G Rinaldi
1Department of Medicine, Duke University Medical Center, Durham, NC 27710.
Abstract:
This communication lists fungi reported to cause invasive infection in patients with AIDS. It excludes the well known and common fungi that infect these patients such as Candida, Cryptococcus, Histoplasma, Coccidioides and Aspergillus. It is likely that these less common fungal pathogens will be seen more frequently in the enlarging AIDS population as it is continuously exposed to many of these potentially opportunistic fungi.
Insights
This study identifies uncommon fungi causing invasive infections in individuals with Acquired Immunodeficiency Syndrome (AIDS). As the AIDS population grows, awareness of these less common fungal pathogens becomes crucial for effective patient management.
Area of Science:
- Mycology
- Infectious Diseases
- Immunology
Background:
- Patients with Acquired Immunodeficiency Syndrome (AIDS) are susceptible to opportunistic infections.
- Common fungal pathogens like Candida and Aspergillus are well-documented in AIDS patients.
- Less common fungal infections in this population require further investigation.
Purpose of the Study:
- To list fungal species, excluding common ones, that cause invasive infections in patients with AIDS.
- To highlight potentially emerging fungal threats in the growing AIDS population.
Main Methods:
- Literature review and compilation of reported cases.
- Exclusion of commonly known fungal pathogens (e.g., Candida, Cryptococcus, Histoplasma, Coccidioides, Aspergillus).
Main Results:
- Identification of several less common fungi causing invasive infections in AIDS patients.
- These pathogens represent a growing concern due to increased exposure in the expanding AIDS demographic.
Conclusions:
- The spectrum of fungal infections in AIDS patients is broader than commonly recognized.
- Clinicians should be vigilant for these less common fungal pathogens in immunocompromised individuals.